CL2022000208A1 - Péptidos reguladores de melanocito - Google Patents

Péptidos reguladores de melanocito

Info

Publication number
CL2022000208A1
CL2022000208A1 CL2022000208A CL2022000208A CL2022000208A1 CL 2022000208 A1 CL2022000208 A1 CL 2022000208A1 CL 2022000208 A CL2022000208 A CL 2022000208A CL 2022000208 A CL2022000208 A CL 2022000208A CL 2022000208 A1 CL2022000208 A1 CL 2022000208A1
Authority
CL
Chile
Prior art keywords
melanocyte
peptides
regulatory peptides
regulatory
sequence
Prior art date
Application number
CL2022000208A
Other languages
English (en)
Spanish (es)
Inventor
Laura Nevola
Martín Santiago Esteban
Original Assignee
Idp Discovery Pharma S L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Idp Discovery Pharma S L filed Critical Idp Discovery Pharma S L
Publication of CL2022000208A1 publication Critical patent/CL2022000208A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/04—Preparations for care of the skin for chemically tanning the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Birds (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
CL2022000208A 2019-08-02 2022-01-26 Péptidos reguladores de melanocito CL2022000208A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP19382674 2019-08-02

Publications (1)

Publication Number Publication Date
CL2022000208A1 true CL2022000208A1 (es) 2022-09-09

Family

ID=67658460

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2022000208A CL2022000208A1 (es) 2019-08-02 2022-01-26 Péptidos reguladores de melanocito

Country Status (14)

Country Link
US (1) US12492225B2 (https=)
EP (1) EP4007563A1 (https=)
JP (2) JP2022542512A (https=)
KR (1) KR20220041094A (https=)
CN (1) CN114245800A (https=)
AR (1) AR119529A1 (https=)
AU (1) AU2020325636A1 (https=)
BR (1) BR112022001729A2 (https=)
CA (1) CA3148785A1 (https=)
CL (1) CL2022000208A1 (https=)
IL (1) IL290019B2 (https=)
MX (1) MX2022001114A (https=)
TW (1) TWI889695B (https=)
WO (1) WO2021023646A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116120401B (zh) * 2023-03-22 2025-09-30 中国科学院昆明动物研究所 一种抗黑色素瘤活性多肽kw13、药物及应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0201863D0 (en) * 2002-06-18 2002-06-18 Cepep Ab Cell penetrating peptides
US20060014712A1 (en) * 2004-05-30 2006-01-19 Cemines, Inc. Controlled delivery of therapeutic compounds
CN106011233A (zh) * 2010-08-13 2016-10-12 莫尔豪斯医学院 中风的生物标记
DK3430031T3 (da) * 2016-03-15 2022-01-17 Idp Discovery Pharma S L Peptider med anti-kræftaktivitet
AU2018311130A1 (en) * 2017-08-02 2020-02-20 Idp Discovery Pharma, S.L. Anticancer peptides
US20210231663A1 (en) * 2017-12-12 2021-07-29 Oncimmune Germany Gmbh Melanoma checkpoint inhibitor detection and treatment

Also Published As

Publication number Publication date
IL290019A (en) 2022-03-01
TW202120117A (zh) 2021-06-01
CA3148785A1 (en) 2021-02-11
TWI889695B (zh) 2025-07-11
AR119529A1 (es) 2021-12-22
JP2025131623A (ja) 2025-09-09
US20230312649A1 (en) 2023-10-05
KR20220041094A (ko) 2022-03-31
AU2020325636A1 (en) 2022-02-10
IL290019B1 (en) 2025-09-01
JP2022542512A (ja) 2022-10-04
BR112022001729A2 (pt) 2022-04-12
MX2022001114A (es) 2022-05-03
WO2021023646A1 (en) 2021-02-11
US12492225B2 (en) 2025-12-09
IL290019B2 (en) 2026-01-01
CN114245800A (zh) 2022-03-25
EP4007563A1 (en) 2022-06-08

Similar Documents

Publication Publication Date Title
ES2619322T3 (es) Agente inductor de inmunidad
MX2022003063A (es) Composiciones terapeuticas, combinaciones y metodos de uso.
CL2019002368A1 (es) Composiciones y métodos para el tratamiento de cáncer.
MX2020008763A (es) Composiciones y metodos para tratar el deterioro auditivo no asociado con la edad en un sujeto humano.
ES2694667T3 (es) Método para producir oxalato oxidasas que tienen actividad óptica cerca de pH fisiológico y uso de tales oxalato oxidasas recombinantes en el tratamiento de enfermedades relacionadas con oxalato
MA37506A1 (fr) Utilisations thérapeutiques de protéines de facteur de croissance des fibroblastes 21
MX2021012659A (es) Composiciones de seda para el cuidado del cabello.
MX2019006515A (es) Composiciones que comprenden peptido wkdeagkplvk.
PE20200722A1 (es) Metodos de terapia genica del factor viii (fviii)
EA202190888A1 (ru) Пептид для применения в косметике
PH12020500029A1 (en) Cosmetic compositions and methods of use
CO2020016105A2 (es) Proteínas inmunodominantes y fragmentos en esclerosis múltiple
PH12019502721A1 (en) Botulinum neurotoxin for treatment of disorders associated with melanocyte hyperactivity and/or excess melanin
PH12021550122A1 (en) Solubilized apyrases, methods and use
MX341020B (es) Peptidos derivados de lactoferrina humana y su uso.
CL2022000208A1 (es) Péptidos reguladores de melanocito
MX376011B (es) Peptidos promotores del crecimiento y usos de los mismos.
MX2023000734A (es) Virus vaccinia recombinante.
EA201690826A1 (ru) Рекомбинантные гликопротеиды и их применения
EA201990526A1 (ru) Конъюгат миноксидила и пептида
MX2025009372A (es) Proteinas/peptidos de fusion, metodos y usos de los mismos
MX2010005280A (es) Nuevos peptidos sinteticos sustituidos con arginina y su uso.
AR115617A1 (es) Composición cosmética para el tratamiento de las fibras de queratina
EA201991738A1 (ru) Новые соединения (иммунорелины)
CR7622A (es) Secuencias del control del gen de corina humano